These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15858397)

  • 1. Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy.
    Flack JM; Sica DA
    J Clin Hypertens (Greenwich); 2005 Apr; 7(4 Suppl 1):9-14. PubMed ID: 15858397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of hypertension in African Americans.
    Ferdinand KC; Armani AM
    Crit Pathw Cardiol; 2007 Jun; 6(2):67-71. PubMed ID: 17667868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meeting the challenge to improve the treatment of hypertension in blacks.
    Lopes AA; James SA; Port FK; Ojo AO; Agodoa LY; Jamerson KA
    J Clin Hypertens (Greenwich); 2003; 5(6):393-401. PubMed ID: 14688494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of hypertensive chronic kidney disease: role of calcium channel blockers.
    Toto RD
    J Clin Hypertens (Greenwich); 2005 Apr; 7(4 Suppl 1):15-20. PubMed ID: 15858398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertension-related morbidity and mortality in African Americans--why we need to do better.
    Ferdinand KC; Saunders E
    J Clin Hypertens (Greenwich); 2006 Jan; 8(1 Suppl 1):21-30. PubMed ID: 16415637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of genes implicated in cardiovascular disease on blood pressure response to treatment among treatment-naive hypertensive African Americans in the GenHAT study.
    Do AN; Lynch AI; Claas SA; Boerwinkle E; Davis BR; Ford CE; Eckfeldt JH; Tiwari HK; Arnett DK; Irvin MR
    J Hum Hypertens; 2016 Sep; 30(9):549-54. PubMed ID: 26791477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes with Angiotensin-converting Enzyme Inhibitors vs Other Antihypertensive Agents in Hypertensive Blacks.
    Bangalore S; Ogedegbe G; Gyamfi J; Guo Y; Roy J; Goldfeld K; Torgersen C; Capponi L; Phillips C; Shah NR
    Am J Med; 2015 Nov; 128(11):1195-203. PubMed ID: 26071821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity.
    Brewster LM; van Montfrans GA; Oehlers GP; Seedat YK
    Intern Emerg Med; 2016 Apr; 11(3):355-74. PubMed ID: 27026378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations for the management of special populations: racial and ethnic populations.
    Ferdinand KC
    Am J Hypertens; 2003 Nov; 16(11 Pt 2):50S-54S. PubMed ID: 14625162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers: their pharmacologic and therapeutic role in hypertension.
    Weir MR
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():5-15. PubMed ID: 19847947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy for hypertension in the elderly: a sub-analysis of the Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial.
    Ogihara T; Matsuzaki M; Umemoto S; Rakugi H; Matsuoka H; Shimada K; Higaki J; Ito S; Kamiya A; Suzuki H; Ohashi Y; Shimamoto K; Saruta T;
    Hypertens Res; 2012 Apr; 35(4):441-8. PubMed ID: 22278623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.
    Norris K; Bourgoigne J; Gassman J; Hebert L; Middleton J; Phillips RA; Randall O; Rostand S; Sherer S; Toto RD; Wright JT; Wang X; Greene T; Appel LJ; Lewis J;
    Am J Kidney Dis; 2006 Nov; 48(5):739-51. PubMed ID: 17059993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).
    Gassman JJ; Greene T; Wright JT; Agodoa L; Bakris G; Beck GJ; Douglas J; Jamerson K; Lewis J; Kutner M; Randall OS; Wang SR
    J Am Soc Nephrol; 2003 Jul; 14(7 Suppl 2):S154-65. PubMed ID: 12819322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication compliance and clinical outcomes of fixed-dose combinations vs free combinations of an angiotensin II receptor blocker and a calcium channel blocker in hypertension treatment.
    Tung YC; Huang YC; Wu LS; Chang CJ; Chu PH
    J Clin Hypertens (Greenwich); 2017 Oct; 19(10):983-989. PubMed ID: 28560786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Antihypertensive Medications on Sepsis-Related Outcomes: A Population-Based Cohort Study.
    Kim J; Kim YA; Hwangbo B; Kim MJ; Cho H; Hwangbo Y; Lee ES
    Crit Care Med; 2019 May; 47(5):e386-e393. PubMed ID: 30688717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.